July 25, 2016 9:33 PM ET

Biotechnology

Company Overview of Protagonist Therapeutics, Inc.

Executive Profile

Mark A. Gallop Ph.D.

Scientific Advisor, Protagonist Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
53--

Background

Dr. Mark A. Gallop, Ph.D., co-founded Xenoport Inc., in 1999. and served as its Senior Vice President of Research from January 2004 to 2010. Dr. Gallop served as Vice President of Chemistry at Xenoport Inc from 1999 to 2004. He serves as Member of Scientific Advisory Board at Protagonist Pty Ltd. He serves as Member of Scientific Advisory Board at Envoy Therapeutics, Inc. Dr. Gallop held several positions at Affymax Research Institute, which was senior director of combinatorial ...

Corporate Headquarters

521 Cottonwood Drive
Milpitas, California 95035

United States

Phone: 408-649-7370
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University of Cambridge
BS
The University of Auckland
Master's Degree
The University of Auckland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Protagonist Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.